BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38077350)

  • 1. Assessment of treatment response in cardiac sarcoidosis based on myocardial
    Frischknecht L; Schaab J; Schmauch E; Yalamanoglu A; Arnold DD; Schwaiger J; Gruner C; Buechel RR; Franzen DP; Kolios AGA; Nilsson J
    Front Immunol; 2023; 14():1286684. PubMed ID: 38077350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Response to Tumor Necrosis Factor-α Inhibitor Therapy in the Management of Cardiac Sarcoidosis.
    Churchill R; Sykora D; Castrichini M; Arment C; Myasoedova E; Elwazir M; Bois J; Young K; Rosenbaum A
    Am J Cardiol; 2023 Oct; 205():20-27. PubMed ID: 37579656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial FDG-PET scans help to identify steroid resistance in cardiac sarcoidosis.
    Shelke AB; Aurangabadkar HU; Bradfield JS; Ali Z; Kumar KS; Narasimhan C
    Int J Cardiol; 2017 Feb; 228():717-722. PubMed ID: 27886616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic role of serial quantitative evaluation of
    Muser D; Santangeli P; Castro SA; Liang JJ; Enriquez A; Werner TJ; Nucifora G; Magnani S; Hayashi T; Zado ES; Garcia FC; Callans DJ; Dixit S; Desjardins B; Marchlinski FE; Alavi A
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1394-1404. PubMed ID: 29610956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-Treatment Myocardial
    Subramanian M; Swapna N; Ali AZ; Saggu DK; Yalagudri S; Kishore J; Swamy LTN; Narasimhan C
    JACC Cardiovasc Imaging; 2021 Oct; 14(10):2008-2016. PubMed ID: 33454258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prednisone vs methotrexate in treatment naïve cardiac sarcoidosis.
    Vis R; Mathijssen H; Keijsers RGM; van de Garde EMW; Veltkamp M; Akdim F; Post MC; Grutters JC
    J Nucl Cardiol; 2023 Aug; 30(4):1543-1553. PubMed ID: 36640249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in ¹⁸F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis.
    Osborne MT; Hulten EA; Singh A; Waller AH; Bittencourt MS; Stewart GC; Hainer J; Murthy VL; Skali H; Dorbala S; Di Carli MF; Blankstein R
    J Nucl Cardiol; 2014 Feb; 21(1):166-74. PubMed ID: 24307261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of Myocardial 18F-FDG Uptake Through Prolonged High-Fat, High-Protein, and Very-Low-Carbohydrate Diet Before FDG-PET/CT for Evaluation of Patients With Suspected Cardiac Sarcoidosis.
    Lu Y; Grant C; Xie K; Sweiss NJ
    Clin Nucl Med; 2017 Feb; 42(2):88-94. PubMed ID: 27922863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of cardiac MRI and 18F-FDG positron emission tomography manifestations and regional response to corticosteroid therapy in newly diagnosed cardiac sarcoidosis with complet heart block.
    Orii M; Hirata K; Tanimoto T; Ota S; Shiono Y; Yamano T; Matsuo Y; Ino Y; Yamaguchi T; Kubo T; Tanaka A; Akasaka T
    Heart Rhythm; 2015 Dec; 12(12):2477-85. PubMed ID: 26111805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Corticosteroid-Sparing Immunosuppression for Cardiac Sarcoidosis.
    Rosenthal DG; Parwani P; Murray TO; Petek BJ; Benn BS; De Marco T; Gerstenfeld EP; Janmohamed M; Klein L; Lee BK; Moss JD; Scheinman MM; Hsia HH; Selby V; Koth LL; Pampaloni MH; Zikherman J; Vedantham V
    J Am Heart Assoc; 2019 Sep; 8(18):e010952. PubMed ID: 31538835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and safety of infliximab in cardiac Sarcoidosis.
    Bakker ALM; Mathijssen H; Azzahhafi J; Swaans MJ; Veltkamp M; Keijsers RGM; Akdim F; Post MC; Grutters JC
    Int J Cardiol; 2021 May; 330():179-185. PubMed ID: 33582196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. F-18 sodium fluoride PET/CT does not effectively image myocardial inflammation due to suspected cardiac sarcoidosis.
    Weinberg RL; Morgenstern R; DeLuca A; Chen J; Bokhari S
    J Nucl Cardiol; 2017 Dec; 24(6):2015-2018. PubMed ID: 27197820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of Active Inflammation Status Around Ventricular Aneurysms in Patients With Cardiac Sarcoidosis.
    Nanno T; Kobayashi S; Yoshitomi R; Fujii S; Kajii T; Kohno M; Ishiguchi H; Okuda S; Okada M; Suga K; Yano M
    Circ J; 2019 Nov; 83(12):2494-2504. PubMed ID: 31631075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.
    Blankstein R; Osborne M; Naya M; Waller A; Kim CK; Murthy VL; Kazemian P; Kwong RY; Tokuda M; Skali H; Padera R; Hainer J; Stevenson WG; Dorbala S; Di Carli MF
    J Am Coll Cardiol; 2014 Feb; 63(4):329-36. PubMed ID: 24140661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Immunosuppressive Therapy and Biopsy Status in Monitoring Therapy Response in Suspected Cardiac Sarcoidosis.
    Rojulpote C; Bhattaru A; Jean C; Adams SL; Patel V; Vidula MK; Selvaraj S; Dubroff J; Peyster E; Clancy CB; Patterson K; Marchlinski FE; Rossman M; Goldberg L; Bravo PE
    JACC Cardiovasc Imaging; 2022 Nov; 15(11):1944-1955. PubMed ID: 36357136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of serial
    Okafor J; Khattar R; Kouranos V; Ohri S; Diana D; Ebeke E; Azzu A; Ahmed R; Wells A; Baksi AJ; Sharma R; Wechalekar K
    J Nucl Cardiol; 2024 May; 35():101842. PubMed ID: 38479574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and Imaging Response to Tumor Necrosis Factor Alpha Inhibitors in Treatment of Cardiac Sarcoidosis: A Multicenter Experience.
    Gilotra NA; Wand AL; Pillarisetty A; Devraj M; Pavlovic N; Ahmed S; Saad E; Solnes L; Garcia C; Okada DR; Constantinescu F; Mohammed SF; Griffin JM; Kasper EK; Chen ES; Sheikh FH
    J Card Fail; 2021 Jan; 27(1):83-91. PubMed ID: 32889044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab for the Treatment of Refractory Cardiac Sarcoidosis: A Single-Center Experience.
    Elwazir M; Krause ML; Bois JP; Christopoulos G; Kendi AT; Cooper JLT; Jouni H; Abouezzeddine OF; Chareonthaitawee P; Abdelshafee M; Amin S
    J Card Fail; 2022 Feb; 28(2):247-258. PubMed ID: 34320381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG-PET/CT and rest myocardial perfusion imaging to predict high-degree atrioventricular block recovery in cardiac sarcoidosis.
    Lucinian YA; Martineau P; Poenaru R; Tremblay-Gravel M; Cadrin-Tourigny J; Harel F; Pelletier-Galarneau M
    J Nucl Cardiol; 2023 Dec; 30(6):2490-2500. PubMed ID: 37258950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of new FDG-PET/CT guidelines for diagnosing cardiac sarcoidosis in patients with implanted cardiac pacemakers for atrioventricular block.
    Tanabe S; Nakano Y; Ando H; Fujimoto M; Onishi T; Ohashi H; Kuno S; Naito K; Waseda K; Takahashi H; Suzuki Y; Fukuta M; Amano T
    Sci Rep; 2024 Apr; 14(1):7825. PubMed ID: 38570621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.